Celcuity, Inc. (CELC)
68.07
+2.27
(+3.45%)
USD |
NASDAQ |
Oct 27, 16:00
69.98
+1.91
(+2.81%)
After-Hours: 20:00
Celcuity Enterprise Value : 3.331B for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 3.331B |
| October 26, 2026 | 3.219B |
| October 23, 2026 | 3.193B |
| October 22, 2026 | 3.208B |
| October 21, 2026 | 3.012B |
| October 20, 2026 | 2.936B |
| October 19, 2026 | 2.795B |
| October 16, 2026 | 2.768B |
| October 15, 2026 | 2.950B |
| October 14, 2026 | 2.931B |
| October 13, 2026 | 3.092B |
| October 12, 2026 | 3.222B |
| October 09, 2026 | 3.324B |
| October 08, 2026 | 3.321B |
| October 07, 2026 | 3.218B |
| October 06, 2026 | 3.486B |
| October 05, 2026 | 3.602B |
| October 02, 2026 | 3.528B |
| October 01, 2026 | 3.676B |
| September 30, 2026 | 3.891B |
| September 29, 2026 | 3.786B |
| September 28, 2026 | 3.897B |
| September 25, 2026 | 3.891B |
| September 24, 2026 | 3.883B |
| September 23, 2026 | 3.914B |
| Date | Value |
|---|---|
| September 22, 2026 | 4.115B |
| September 21, 2026 | 4.110B |
| September 18, 2026 | 3.944B |
| September 17, 2026 | 4.154B |
| September 16, 2026 | 4.040B |
| September 15, 2026 | 4.046B |
| September 14, 2026 | 4.087B |
| September 11, 2026 | 4.083B |
| September 10, 2026 | 4.183B |
| September 09, 2026 | 4.407B |
| September 08, 2026 | 4.551B |
| September 04, 2026 | 4.682B |
| September 03, 2026 | 4.718B |
| September 02, 2026 | 4.707B |
| September 01, 2026 | 4.500B |
| August 31, 2026 | 4.357B |
| August 28, 2026 | 4.327B |
| August 27, 2026 | 4.562B |
| August 26, 2026 | 4.652B |
| August 25, 2026 | 4.514B |
| August 24, 2026 | 4.442B |
| August 21, 2026 | 4.576B |
| August 20, 2026 | 4.431B |
| August 19, 2026 | 4.582B |
| August 18, 2026 | 4.562B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Beam Therapeutics, Inc. | 1.666B |
| Vera Therapeutics, Inc. | 1.734B |
| Tango Therapeutics, Inc. | 2.872B |
| Sarepta Therapeutics, Inc. | 2.253B |
| Twist Bioscience Corp. | 9.945B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -78.86M |
| Total Expenses (Quarterly) | 78.86M |
| EPS Diluted (Quarterly) | -1.439 |
| Earnings Yield | -6.32% |
| Normalized Earnings Yield | -6.101 |